tirzepatide use for FDA approval Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Buy Tirzepatide (20 mg) |

Multiple people called me at different times to move things forward

In the 2025 RAND survey, about half of patients taking a GLP-1 drug said they experienced nausea and one-third experienced diarrhea

The Changes to GLP-1 Access in 2026 Medicare Is Now Covering GLP-1s for Weight Loss Federal law previously blocked Medicare from covering weight-loss drugs

Our facility is equipped with the latest technology to ensure that your treatment is both safe and effective

You work hard to reduce body fat, achieve your target weight, and then find yourself dealing with sagging skin that obscures your results

10% 22.6% 17.4%( 9.7%)